Home > Publications database > Protein-Protein Interactions in Drug Discovery. Edited by Alexander Dömling. > print

001     153364
005     20210129213728.0
024 7 _ |a 10.1002/cbic.201300761
|2 doi
024 7 _ |a 1439-7633
|2 ISSN
024 7 _ |a 1439-4227
|2 ISSN
037 _ _ |a FZJ-2014-02995
082 _ _ |a 540
100 1 _ |a Strodel, Birgit
|0 P:(DE-Juel1)132024
|b 0
|e Corresponding Author
|u fzj
245 _ _ |a Protein-Protein Interactions in Drug Discovery. Edited by Alexander Dömling.
260 _ _ |a Weinheim
|c 2014
|b Wiley-VCH
295 1 0 |a Protein–Protein Interactions in Drug Discovery. Edited by Alexander Dömling.
336 7 _ |a Review
|b review
|m review
|0 PUB:(DE-HGF)36
|s 1399275531_3040
|2 PUB:(DE-HGF)
336 7 _ |a Journal Article
|0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|m journal
336 7 _ |a Contribution to a book
|0 PUB:(DE-HGF)7
|2 PUB:(DE-HGF)
|m contb
336 7 _ |a review
|2 DRIVER
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a BOOK_REVIEW
|2 ORCID
336 7 _ |a Output Types/Book Review
|2 DataCite
336 7 _ |a ARTICLE
|2 BibTeX
520 _ _ |a Protein–protein interactions (PPIs) are central to most biological processes, and represent novel targets for therapeutic intervention. It was once thought that protein–protein interfaces could not be modulated by small molecules. However, examples of successful PPI inhibitors have accumulated in recent years. The book edited by Dömling presents general strategies and recent developments in the modulation of protein–protein interactions for therapeutic intervention, and provides an overview of the current status of this emerging field.
536 _ _ |a 452 - Structural Biology (POF2-452)
|0 G:(DE-HGF)POF2-452
|c POF2-452
|f POF II
|x 0
588 _ _ |a Dataset connected to CrossRef, juser.fz-juelich.de
773 _ _ |a 10.1002/cbic.201300761
|g Vol. 15, no. 3, p. 472 - 473
|0 PERI:(DE-600)2020469-3
|n 3
|p 472 - 473
|t ChemBioChem
|v 15
|y 2014
|x 1439-4227
856 4 _ |u https://juser.fz-juelich.de/record/153364/files/FZJ-2014-02995.pdf
|z Published final document.
|y Restricted
909 C O |o oai:juser.fz-juelich.de:153364
|p VDB
910 1 _ |a Forschungszentrum Jülich GmbH
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)132024
913 2 _ |a DE-HGF
|b Key Technologies
|l BioSoft Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences
|1 G:(DE-HGF)POF3-550
|0 G:(DE-HGF)POF3-553
|2 G:(DE-HGF)POF3-500
|v Physical Basis of Diseases
|x 0
913 1 _ |a DE-HGF
|b Schlüsseltechnologien
|1 G:(DE-HGF)POF2-450
|0 G:(DE-HGF)POF2-452
|2 G:(DE-HGF)POF2-400
|v Structural Biology
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF2
|l BioSoft
914 1 _ |y 2014
915 _ _ |a JCR/ISI refereed
|0 StatID:(DE-HGF)0010
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
920 1 _ |0 I:(DE-Juel1)ICS-6-20110106
|k ICS-6
|l Strukturbiochemie
|x 0
980 _ _ |a review
980 _ _ |a VDB
980 _ _ |a journal
980 _ _ |a contb
980 _ _ |a I:(DE-Juel1)ICS-6-20110106
980 _ _ |a UNRESTRICTED
981 _ _ |a I:(DE-Juel1)IBI-7-20200312

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21